Agilent Technologies (A)Director sold ~$217K

~$217K

Approx. value · 1,600 sh @ $135.42

5,548.39

Holds after · shares reported

Traded

May 29, 2026

Filed

Jun 2, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 23, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
2. Mar 31, 2026Company filing · Form 8-K · Change of controlControl of the company changed hands
3. Mar 31, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 31, 2026, Bret DiMarco, Senior Vice President, Chief Legal Officer and Secretary of Agilent Technologies, Inc. (the “Company”), entered into a transition and general release agreement with the Company (the “Transition Agreement”) pursuant to which Mr. DiMarco will resign from such roles upon the earlier to occur of the start date of a new Chief Legal Officer or September 30, 2026.”
4. Apr 3, 2026Federal contract · $1.9M obligatedDepartment of Health and Human Services awarded Agilent Technologies: $1.95M obligated to date
5. Apr 28, 20265% stakeVanguard Portfolio Management reported a passive stake (13G) of 5.1%
6. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
7. May 4, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On May 4, 2026, the Company appointed Michael Buckner as the new Chief Legal Officer and, as a result, effective on such date, Mr. DiMarco resigned from his positions as Senior Vice President, Chief Legal Officer and Secretary of the Company.”
8. May 20, 2026Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results“On May 20, 2026, the Company appointed Tim Downs as the new Vice President, Chief Accounting Officer of the Company and as principal accounting officer of the Company, effective as of the first business day following the Company’s filing of the quarterly report on Form 10-Q for the quarter ended April 30, 2026 (the “Start Date”).”
9. May 20, 2026Federal contract · $698K obligatedDepartment of Health and Human Services awarded Agilent Technologies: $698K obligated to date
10. May 29, 2026 · this disclosureInsiderDirector sold ~$217K of A shares in the open market

What came next

1. Jun 25, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
2. Jul 21, 2026Federal contract · $670K obligatedDepartment of Agriculture awarded Agilent Technologies: $670K obligated to date
3. Aug 18, 2026Federal contract · $731K obligatedDepartment of Health and Human Services awarded Agilent Technologies: $731K obligated to date
4. Aug 26, 2026Company filing · Form 8-K · ResultsReported its results
5. Sep 2, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 2, 2026, Boon Hwee Koh, Chairperson of the Board of Directors (the "Board") of Agilent Technologies, Inc. (the "Company"), notified the Company of his decision to retire from the Board, effective as of September 4, 2026.”
6. Sep 4, 2026InsiderDirector sold ~$96K of A shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Agilent Technologies

For Agilent Technologies, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports, 21 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its A page.

Other recent filings by Mikael Dolsten, Director

• SEC Form 4 at Agilent Technologies (A)Sep 9, 2026
• SEC Form 4 at Agilent Technologies (A)Dec 3, 2025

The full history of Mikael Dolsten, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Agilent Technologies

• USAspending.gov award recordSep 29, 2026
• USAspending.gov award recordSep 28, 2026
• SEC Form 4Sep 9, 2026
• SEC Form 144Sep 4, 2026
• USAspending.gov award recordAug 18, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its A page.